I am an alum of Vanderbilt University. Since 2020, I have held operational roles at several clinically-staged biotechs focusing on oncology and cardiovascular disease. I am currently Chief Business Officer of Abcentra, a Cedars Sinai spinout focused on coronary inflammation. My experience includes raising equity financing through multiple venture rounds from leading life science investors. Prior to getting involved with biotech, I spent almost two decades in various investment management roles across asset classes.

To meet with John, or any of our excellent mentors, please fill out this interest form.